Waters
WAT
Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them
Managers holding
7
In their latest 13F (Q3 2026)
See who
Value held
$1.6bn
Combined value at quarter end
Last quarter
2 bought
5 sold or trimmed
Fund portfolios
3
Funds holding it
See which
Price at Q2 ’26 end
$375.04
+25.9% in the quarter
Share price change by quarter
+24.0%Q3 ’24
+3.1%Q4 ’24
-0.6%Q1 ’25
-5.3%Q2 ’25
-14.1%Q3 ’25
+26.7%Q4 ’25
-21.6%Q1 ’26
+25.9%Q2 ’26
Managers holding it, by quarter
3Q4 ’23
3Q1 ’24
3Q2 ’24
3Q3 ’24
3Q4 ’24
3Q1 ’25
3Q2 ’25
3Q3 ’25
3Q4 ’25
7Q1 ’26
7Q2 ’26
0Q3 ’26
Who holds it
| Fundsmith | 6.3%$853m | Trimmed -29% |
| AKO Capital | 1.8%$76.3m | Trimmed -75% |
| First Pacific Advisors (FPA) | 1.2%$101m | Added +0.3% |
| First Eagle Investment Management | 0.8%$501m | Trimmed -15% |
| Jensen Investment Management | 0.3%$14.5m | Trimmed -0.5% |
| Harris Associates (Oakmark) | 0.0%$6.9m | Trimmed -94% |
| Mairs & Power | 0.0%$360k | Added +0.1% |
Directors buying and selling
How this works
| Bought or sold | ||||
|---|---|---|---|---|
| 6 Aug 2026 | Kuebler Christopher ADirector | ▼ Sold | 3,626 | $1.4m |
About the company
- Sector
- Technology · Laboratory Analytical Instruments
- Incorporated in
- Delaware
- Financial year ends
- 31 December
- Shares outstanding
- 98m at 7 Aug 2026
- SEC filings
- Annual reports and other filings on EDGAR
Revenue and profit
$1.9bn2013
$2.0bn2015
$2.3bn2017
$2.4bn2019
$2.8bn2021
$3.0bn2023
$3.2bn2025
| Year | Revenue | Net income |
|---|---|---|
| 2025 | $3.2bn | $643m |
| 2024 | $3.0bn | $638m |
| 2023 | $3.0bn | $642m |
| 2022 | $3.0bn | $708m |
| 2021 | $2.8bn | $693m |
| 2020 | $2.4bn | – |
| 2019 | $2.4bn | – |
| 2018 | $2.4bn | – |
| 2017 | $2.3bn | – |
| 2016 | $2.2bn | – |
| 2015 | $2.0bn | – |
| 2014 | $2.0bn | – |
| 2013 | $1.9bn | – |
In fund portfolios
| Fundsmith Equity ETFFundsmith | 5.6% |
| FPA Crescent FundFirst Pacific Advisors (FPA) | 0.5% |
| First Eagle Global FundFirst Eagle Investment Management | 0.3% |